These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 34032919)

  • 1. Influence of the Dabcyl group on the cellular uptake of cationic peptides: short oligoarginines as efficient cell-penetrating peptides.
    Szabó I; Illien F; Dókus LE; Yousef M; Baranyai Z; Bősze S; Ise S; Kawano K; Sagan S; Futaki S; Hudecz F; Bánóczi Z
    Amino Acids; 2021 Jul; 53(7):1033-1049. PubMed ID: 34032919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Balance between Hydrophobicity/Aromaticity and Positively Charged Residues May Influence the Cell Penetration Ability.
    Soltész D; Szabó I; Bánóczi Z
    Pharmaceutics; 2023 Apr; 15(4):. PubMed ID: 37111751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced Live-Cell Delivery of Synthetic Proteins Assisted by Cell-Penetrating Peptides Fused to DABCYL.
    Mandal S; Mann G; Satish G; Brik A
    Angew Chem Int Ed Engl; 2021 Mar; 60(13):7333-7343. PubMed ID: 33615660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-Penetrating Dabcyl-Containing Tetraarginines with Backbone Aromatics as Uptake Enhancers.
    Yousef M; Szabó I; Murányi J; Illien F; Soltész D; Bató C; Tóth G; Batta G; Nagy P; Sagan S; Bánóczi Z
    Pharmaceutics; 2022 Dec; 15(1):. PubMed ID: 36678772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Preorganized Charge-Display on the Cell-Penetrating Properties of Cationic Peptides.
    Nagel YA; Raschle PS; Wennemers H
    Angew Chem Int Ed Engl; 2017 Jan; 56(1):122-126. PubMed ID: 27900805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of conjugation on antitumor activity of vindoline derivatives with octaarginine, a cell-penetrating peptide.
    Bánóczi Z; Keglevich A; Szabó I; Ranđelović I; Hegedüs Z; Regenbach FL; Keglevich P; Lengyel Z; Gorka-Kereskényi Á; Dubrovay Z; Háda V; Szigetvári Á; Szántay C; Hazai L; Tóvári J; Hudecz F
    J Pept Sci; 2018 Oct; 24(10):e3118. PubMed ID: 30084214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CyLoP-1: a novel cysteine-rich cell-penetrating peptide for cytosolic delivery of cargoes.
    Jha D; Mishra R; Gottschalk S; Wiesmüller KH; Ugurbil K; Maier ME; Engelmann J
    Bioconjug Chem; 2011 Mar; 22(3):319-28. PubMed ID: 21319732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancing antitumor activity of silver nanoparticles by modification with cell-penetrating peptides.
    Mussa Farkhani S; Asoudeh Fard A; Zakeri-Milani P; Shahbazi Mojarrad J; Valizadeh H
    Artif Cells Nanomed Biotechnol; 2017 Aug; 45(5):1029-1035. PubMed ID: 27357085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and cellular characterization of various nano-assemblies of cell penetrating peptide-epirubicin-polyglutamate conjugates for the enhancement of antitumor activity.
    Mohammadi S; Zakeri-Milani P; Golkar N; Farkhani SM; Shirani A; Shahbazi Mojarrad J; Nokhodchi A; Valizadeh H
    Artif Cells Nanomed Biotechnol; 2018 Dec; 46(8):1572-1585. PubMed ID: 28933182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PEGylated liposomes with NGR ligand and heat-activable cell-penetrating peptide-doxorubicin conjugate for tumor-specific therapy.
    Yang Y; Yang Y; Xie X; Cai X; Zhang H; Gong W; Wang Z; Mei X
    Biomaterials; 2014 May; 35(14):4368-81. PubMed ID: 24565519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient intracellular delivery of nucleic acid pharmaceuticals using cell-penetrating peptides.
    Nakase I; Akita H; Kogure K; Gräslund A; Langel U; Harashima H; Futaki S
    Acc Chem Res; 2012 Jul; 45(7):1132-9. PubMed ID: 22208383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kiss and Run: Promoting Effective and Targeted Cellular Uptake of a Drug Delivery Vehicle Composed of an Integrin-Targeting Diketopiperazine Peptidomimetic and a Cell-Penetrating Peptide.
    Feni L; Parente S; Robert C; Gazzola S; Arosio D; Piarulli U; Neundorf I
    Bioconjug Chem; 2019 Jul; 30(7):2011-2022. PubMed ID: 31243977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent developments in anticancer drug delivery using cell penetrating and tumor targeting peptides.
    Dissanayake S; Denny WA; Gamage S; Sarojini V
    J Control Release; 2017 Mar; 250():62-76. PubMed ID: 28167286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of a Cell-Penetrating Peptide with Potential Anticancer Activity.
    Gronewold A; Horn M; Ranđelović I; Tóvári J; Muñoz Vázquez S; Schomäcker K; Neundorf I
    ChemMedChem; 2017 Jan; 12(1):42-49. PubMed ID: 27860402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-Uptake Relationship Study of DABCYL Derivatives Linked to Cyclic Cell-Penetrating Peptides for Live-Cell Delivery of Synthetic Proteins.
    Saha A; Mandal S; Arafiles JVV; Gómez-González J; Hackenberger CPR; Brik A
    Angew Chem Int Ed Engl; 2022 Nov; 61(47):e202207551. PubMed ID: 36004945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enantiomeric and diastereoisomeric (mixed) L/ D-octaarginine derivatives - a simple way of modulating the properties of cell-penetrating peptides.
    Purkayastha N; Eyer K; Robinson T; Dittrich PS; Beck AK; Seebach D; Kolesinska B; Cadalbert R
    Chem Biodivers; 2013 Jul; 10(7):1165-84. PubMed ID: 23847063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current Delivery Strategies to Improve the Target of Cell Penetrating Peptides Used for Tumor-Related Therapeutics.
    Zhang F; Yang D; Jiang S; Wu L; Qin L; He H; Zhang P
    Curr Pharm Des; 2018; 24(5):541-548. PubMed ID: 28758600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell-penetrating peptides: achievements and challenges in application for cancer treatment.
    Shin MC; Zhang J; Min KA; Lee K; Byun Y; David AE; He H; Yang VC
    J Biomed Mater Res A; 2014 Feb; 102(2):575-87. PubMed ID: 23852939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanistic study of the uptake/permeation of cell-penetrating peptides across a caco-2 monolayer and their stimulatory effect on epithelial insulin transport.
    Kamei N; Onuki Y; Takayama K; Takeda-Morishita M
    J Pharm Sci; 2013 Nov; 102(11):3998-4008. PubMed ID: 23963728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell penetration: scope and limitations by the application of cell-penetrating peptides.
    Reissmann S
    J Pept Sci; 2014 Oct; 20(10):760-84. PubMed ID: 25112216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.